In a real-world registry of patients with atrial fibrillation treated with a pulsed field ablation catheter, the system was associated with favorable 30-day outcomes, researchers reported at Heart Rhythm 2024. Lucas V. A. Boersma, MD, PhD, FESC, professor of Innovative Transcatheter Treatments for Cardiac Arrhythmias at the University of Amsterdam’s Faculty of Medicine and head of the